<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04055961</url>
  </required_header>
  <id_info>
    <org_study_id>171-19-CV</org_study_id>
    <nct_id>NCT04055961</nct_id>
  </id_info>
  <brief_title>Atrial Fibrillation Ablation Registry</brief_title>
  <acronym>AFib</acronym>
  <official_title>Atrial Fibrillation Ablation Registry Protocol Number: 3122-2016</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hoag Memorial Hospital Presbyterian</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hoag Memorial Hospital Presbyterian</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Atrial Fibrillation Ablation Registry (AFib Ablation Registry™) is designed to assess the
      prevalence, demographics, management, and outcomes of patients undergoing percutaneous
      catheter ablation procedures to treat atrial fibrillation (AF).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Atrial Fibrillation Ablation Registry (AFib Ablation Registry™) is designed to assess the
      prevalence, demographics, management, and outcomes of patients undergoing percutaneous
      catheter ablation procedures to treat atrial fibrillation (AF). Patient-level data will be
      submitted by participating hospitals on a quarterly basis to the American College of
      Cardiology Foundation's National Cardiovascular Data Registry (NCDR™). The primary aims of
      the AFib Ablation Registry are to optimize the outcomes and management of patients through
      the implementation of evidence-based guideline recommendations in clinical practice,
      facilitate efforts to improve the quality and safety for patients undergoing percutaneous
      catheter ablation procedures, investigate novel quality improvement methods and provide
      risk-adjusted assessment of patients for comparison with nationwide NCDR data. The secondary
      purpose of the AFib Ablation Registry is to serve as a rich source of clinical data to
      support assessments of short- and long-term safety, comparative and cost effectiveness
      research, and as a scalable data infrastructure for post market studies.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 20, 2019</start_date>
  <completion_date type="Anticipated">May 20, 2025</completion_date>
  <primary_completion_date type="Anticipated">May 20, 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Unsuccessful treatment rate</measure>
    <time_frame>1 year</time_frame>
    <description>measured by the number of repeated procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>1 year</time_frame>
    <description>Number of participants with adverse events that are related to treatment (i.e. cardiac tamponade, periprocedural stroke, pulmonary vein stenosis, esophageal damage, etc)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Atrial Fibrillation</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Atrial Fibrillation Ablation</intervention_name>
    <description>A procedure used to treat an irregular heart rhythm (arrhythmia)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients, 18 years and older, undergoing percutaneous catheter ablation procedures to
        treat atrial fibrillation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients, 18 years and older, undergoing percutaneous catheter ablation
             procedures to treat atrial fibrillation

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hoah Memorial Hospital Presbyterian</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colleen Balius, BSN, RN</last_name>
      <phone>949-764-1497</phone>
      <email>colleen.balius@hoag.org</email>
    </contact>
    <investigator>
      <last_name>Colleen Balius, BSN, RN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 8, 2019</study_first_submitted>
  <study_first_submitted_qc>August 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2019</study_first_posted>
  <last_update_submitted>August 12, 2019</last_update_submitted>
  <last_update_submitted_qc>August 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hoag Memorial Hospital Presbyterian</investigator_affiliation>
    <investigator_full_name>Colleen Balius</investigator_full_name>
    <investigator_title>Clinical Data Coordinator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

